Actavis Pharma Updates Ciclopirox Shampoo Prescribing Information as of September 10, 2026

Actavis Pharma, Inc. updated the prescribing information for Ciclopirox shampoo on September 10, 2026. The updated documentation outlines the clinical usage, safety profile, and administration guidelines for the antifungal medication, which healthcare providers prescribe for the treatment of seborrheic dermatitis of the scalp.

The updated filing provides comprehensive data regarding the product’s chemical composition, contraindications, and potential adverse reactions. It details the recommended application frequency for patients and specifies the necessary precautions for individuals with known hypersensitivity to any components of the formulation. The document also includes information on clinical pharmacology, describing how the active ingredient interacts with the skin to manage fungal growth. These updates serve as the current regulatory reference for pharmacists and physicians managing patient treatment plans involving this specific shampoo.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: September 10, 2026

Author

GOAI